BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Roflumilast (Daliresp) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Roflumilast (Daliresp)\, from ClinicalTri
 als.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07795086-11035@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:Roflumilast (Daliresp): Phase 4 readout est. (NCT07795086)
DESCRIPTION:Roflumilast (Daliresp)\, phase 4\, Chronic Obstructive Pulmonar
 y Disease.\nStudy: Comparative Effectiveness of Roflumilast and Azithromyc
 in in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disea
 se ( COPD ) Patients With Chronic Bronchitis Phenotype\nEstimated primary 
 completion: February 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/roflumilast-daliresp#upcoming-events\nRegistry record: https://clini
 caltrials.gov/study/NCT07795086
URL:https://assetmemo.bio/drug/roflumilast-daliresp#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06860958-11035@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20270320
DTEND;VALUE=DATE:20270321
SUMMARY:Roflumilast (Daliresp): Phase 3 readout est. (NCT06860958)
DESCRIPTION:Roflumilast (Daliresp)\, phase 3.\nStudy: Roflumilast as an Adj
 unct to Antidepressants in Major Depressive Disorder Patients\nEstimated p
 rimary completion: 20 March 2027. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/roflumilast-daliresp#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT06860958
URL:https://assetmemo.bio/drug/roflumilast-daliresp#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07566351-11035@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Roflumilast (Daliresp): Phase 2 readout est. (NCT07566351)
DESCRIPTION:Roflumilast (Daliresp)\, phase 2.\nStudy: Effect of Roflumilast
  and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis
 \nEstimated primary completion: June 2027. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/roflumilast-daliresp#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT07566351
URL:https://assetmemo.bio/drug/roflumilast-daliresp#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07900087-11035@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20270801
DTEND;VALUE=DATE:20270802
SUMMARY:Roflumilast (Daliresp): Phase 2/3 readout est. (NCT07900087)
DESCRIPTION:Roflumilast (Daliresp)\, phase 2/3.\nStudy: Evaluating the Safe
 ty and Efficacy of Roflumilast in the Treatment of Nonalcoholic Fatty Live
 r Disease Patients\nEstimated primary completion: 1 August 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/roflumilast-daliresp#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT07900087
URL:https://assetmemo.bio/drug/roflumilast-daliresp#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07352566-11035@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20300601
DTEND;VALUE=DATE:20300602
SUMMARY:Roflumilast (Daliresp): Phase 4 readout est. (NCT07352566)
DESCRIPTION:Roflumilast (Daliresp)\, phase 4.\nStudy: Utilization of a Micr
 odevice for Psoriasis and Atopic Dermatitis\nEstimated primary completion:
  1 June 2030. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/roflumi
 last-daliresp#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07352566
URL:https://assetmemo.bio/drug/roflumilast-daliresp#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
